lmmunomodulation - a disease-modifying avenue for treatment of Huntington's disease?

被引：3
|
作者：
Bjorkqvist, Maria [1 ]
机构：
[1] Lund Univ, Wallenberg Neurosci Ctr, Dept Expt Med Sci, Brain Dis Biomarker Unit, BMC A10, S-22184 Lund, Sweden
来源：
JOURNAL OF NEUROCHEMISTRY | 2016年 / 137卷 / 05期
关键词：
PATHWAY;
D O I：
10.1111/jnc.13539
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
[No abstract available]
引用
收藏
页码：670 / 672
页数：3
相关论文
共 50 条
  • [21] Disease-Modifying Drugs in Parkinson’s Disease
    Ariane Park
    Mark Stacy
    Drugs, 2015, 75 : 2065 - 2071
  • [22] Disease-modifying drugs and Parkinson's disease
    Allain, Herve
    Bentue-Ferrer, Daniele
    Akwa, Yvette
    PROGRESS IN NEUROBIOLOGY, 2008, 84 (01) : 25 - 39
  • [23] Disease-modifying treatments in Alzheimer’s disease
    Marc Edwards
    Robin Corkill
    Journal of Neurology, 2023, 270 : 2342 - 2344
  • [24] Disease-modifying treatments in Alzheimer's disease
    Edwards, Marc
    Corkill, Robin
    JOURNAL OF NEUROLOGY, 2023, 270 (04) : 2342 - 2344
  • [25] Disease-modifying drugs in Alzheimer's disease
    Ghezzi, Laura
    Scarpini, Elio
    Galimberti, Daniela
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2013, 7 : 1471 - 1479
  • [26] Disease-Modifying Drugs in Parkinson's Disease
    Park, Ariane
    Stacy, Mark
    DRUGS, 2015, 75 (18) : 2065 - 2071
  • [27] Disease-modifying therapies in Alzheimer's disease
    Salloway, Stephen
    Mintzer, Jacobo
    Weiner, Myron F.
    Cummings, Jeffrey L.
    ALZHEIMERS & DEMENTIA, 2008, 4 (02) : 65 - 79
  • [28] Disease-Modifying Strategies for Parkinson's Disease
    Kalia, Lorraine V.
    Kalia, Suneil K.
    Lang, Anthony E.
    MOVEMENT DISORDERS, 2015, 30 (11) : 1442 - 1450
  • [29] Canadian healthcare capacity gaps for disease-modifying treatment in Huntington's disease: a survey of current practice and modelling of future needs
    Benard, Angele
    Chouinard, Sylvain
    Leavitt, Blair R.
    Budd, Nathalie
    Wu, Jennifer W.
    Schoffer, Kerrie
    BMJ OPEN, 2022, 12 (06):
  • [30] Translational research in Huntington's disease: Opening up for disease modifying treatment
    Burgunder J.-M.
    Translational Neurodegeneration, 2 (1)
12345